My Quote Request
No products added yet
6505-01-074-6598
20 Products
NDC00002-7061-25
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010746598
NSN
6505-01-074-6598
NDC00002-7061-25
CEFAMANDOLE NAFATE FOR INJECTION,USP
NSN, MFG P/N
6505010746598
NSN
6505-01-074-6598
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 1 GM CEFAMANDOLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFAMANDOLE NAFATE FOR INJECTION USP 1GM 10ML VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO CONTAIN 1 GM OF CEFAMANDOLE
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML-SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
MELLARIL-S
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
MELLARIL-S
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 20.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MELLARIL-S SUSPENSION
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
MELLARIL-S SUSPENSION
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 20.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00078-0069-33
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
NDC00078-0069-33
THIORIDAZINE ORAL SUSPENSION,USP
NSN, MFG P/N
6505010747586
NSN
6505-01-074-7586
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 20.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
3356
CEFOXITIN FOR INJECTION,USP
NSN, MFG P/N
6505010747588
NSN
6505-01-074-7588
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 1 GRAM OF CEFOXITIN
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 1 GRAM OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML-SIZE VIAL
Related Searches:
MEFOXIN
CEFOXITIN FOR INJECTION,USP
NSN, MFG P/N
6505010747588
NSN
6505-01-074-7588
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 1 GRAM OF CEFOXITIN
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 1 GRAM OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML-SIZE VIAL
Related Searches:
NDC00006-3356-71
CEFOXITIN FOR INJECTION,USP
NSN, MFG P/N
6505010747588
NSN
6505-01-074-7588
NDC00006-3356-71
CEFOXITIN FOR INJECTION,USP
NSN, MFG P/N
6505010747588
NSN
6505-01-074-7588
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 1 GRAM OF CEFOXITIN
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO PROVIDE 1 GRAM OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML-SIZE VIAL
Related Searches:
NDC00015-3070-20
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010747590
NSN
6505-01-074-7590
NDC00015-3070-20
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010747590
NSN
6505-01-074-7590
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CISPLATIN ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
PLATINOL
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010747590
NSN
6505-01-074-7590
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CISPLATIN ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00007-5079-19
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010747738
NSN
6505-01-074-7738
NDC00007-5079-19
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010747738
NSN
6505-01-074-7738
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
THORAZINE
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010747738
NSN
6505-01-074-7738
THORAZINE
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010747738
NSN
6505-01-074-7738
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
041-00
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010747741
NSN
6505-01-074-7741
041-00
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010747741
NSN
6505-01-074-7741
MFG
RESPIRATORY CARE INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, NEBULIZER
SPECIAL FEATURES: WITH NEBULIZER ADAPTOR ENCLOSED
Related Searches:
AQUAPAK 1021
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010747741
NSN
6505-01-074-7741
AQUAPAK 1021
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010747741
NSN
6505-01-074-7741
MFG
RESPIRATORY CARE INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, NEBULIZER
SPECIAL FEATURES: WITH NEBULIZER ADAPTOR ENCLOSED
Related Searches:
FULVICIN P/G
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
FULVICIN P/G
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BIOLOGICALLY EQUIVALENT TO 500 MG OF MICROSIZED GRISEOFULVIN
Related Searches:
NDC00043-0072-51
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
NDC00043-0072-51
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BIOLOGICALLY EQUIVALENT TO 500 MG OF MICROSIZED GRISEOFULVIN
Related Searches:
NDC00046-0435-81
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
NDC00046-0435-81
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BIOLOGICALLY EQUIVALENT TO 500 MG OF MICROSIZED GRISEOFULVIN
Related Searches:
NDC00085-0507-03
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
NDC00085-0507-03
GRISEOFULVIN TABLETS,ULTRAMICROSIZE,USP
NSN, MFG P/N
6505010748034
NSN
6505-01-074-8034
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: BIOLOGICALLY EQUIVALENT TO 500 MG OF MICROSIZED GRISEOFULVIN
Related Searches:
1431
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505010748164
NSN
6505-01-074-8164
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
MIN-I-JET SYSTEM
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505010748164
NSN
6505-01-074-8164
MIN-I-JET SYSTEM
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505010748164
NSN
6505-01-074-8164
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
ATIVAN REDIPAK
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505010749346
NSN
6505-01-074-9346
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
TOTAL PRIMARY CONTAINER QUANTITY: 1
